A carregar...
Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma
Background: Wixela(®) Inhub(®) is a dry powder inhaler approved as a generic equivalent to Advair(®) Diskus(®) (fluticasone propionate [FP]/salmeterol fixed-dose combination) for patients with asthma or chronic obstructive pulmonary disease (COPD). This study aimed at confirming the local (lung) the...
Na minha lista:
| Publicado no: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mary Ann Liebert, Inc., publishers
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7133441/ https://ncbi.nlm.nih.gov/pubmed/31634023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2019.1547 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|